home.social

#nutrition — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #nutrition, aggregated by home.social.

  1. DATE: November 19, 2026 at 06:00AM
    SOURCE: PSYPOST.ORG

    ** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
    -------------------------------------------------

    TITLE: Daily peanut consumption may improve brain insulin responsiveness in older adults

    URL: psypost.org/daily-peanut-consu

    Eating about two handfuls of unsalted, skin-roasted peanuts every day for four months may alter how memory-related areas of the aging brain respond to the hormone insulin, according to a clinical trial published in Food & Function.

    In a randomized study of healthy older adults, daily peanut intake shifted blood-flow responses to an insulin nasal spray within a right-hemisphere brain cluster that includes part of the hippocampus, even as liver fat, blood sugar, and cholesterol levels remained largely unchanged. The findings point to a potential biological pathway that could help explain why regular peanut consumption has been linked to better memory in older age.

    How insulin acts in the aging brain

    Insulin is a hormone produced by the pancreas that is best known for helping cells throughout the body absorb sugar from the bloodstream. Although the brain takes up most of its glucose without insulin’s help, dense concentrations of insulin receptors sit on brain cells in regions such as the prefrontal cortex, the hypothalamus, and the hippocampus, a seahorse-shaped structure deep in the temporal lobe that is essential for forming and recalling memories.

    “The hormone insulin plays an important role in the brain, where it supports memory and other cognitive processes,” principal investigator and senior author Peter J. Joris, an associate professor in the Department of Nutrition and Movement Sciences at the Institute of Nutrition and Translational Research in Metabolism at Maastricht University, told PsyPost.

    Brain insulin responsiveness refers to the ability of specific brain areas to adjust their neural activity when exposed to this hormone, supporting circuits that regulate memory, appetite, and energy balance. When brain tissue becomes less responsive to insulin, a condition often called brain insulin resistance, that dysfunction is associated with metabolic conditions like type 2 diabetes as well as age-related cognitive decline and neurodegenerative disorders such as Alzheimer’s disease.

    How strongly the brain responds to insulin is not fixed, and everyday habits appear able to shift it: eating a high-calorie, high-fat diet over a short period can dampen brain insulin signaling, whereas regular aerobic exercise can help restore it in adults with overweight or obesity. Nutritional researchers have also begun examining whether nutrient-dense foods like nuts and peanuts offer similar support for the aging brain.

    In a 2025 clinical trial of healthy older adults conducted by the same researchers and analyzing data from the same experiment, published in Clinical Nutrition, eating 60 grams of unsalted, skin-roasted peanuts daily for 16 weeks increased global blood flow in the brain by 3.6 percent, improved verbal memory performance by 5.8 percent, and lowered systolic blood pressure compared with a peanut-free period.

    “Our study suggested that regularly eating unsalted, skin-roasted peanuts may support brain health and improve cognitive performance in healthy older adults,” Joris explained.

    Working alongside first author Lucia Kerkhof and colleagues at Maastricht University in the Netherlands, Joris also examined whether daily peanut intake affected brain insulin responsiveness, the trial’s other primary outcome measured during the same study visits. Because the brain and liver function as metabolically connected organs, the scientists additionally tracked fat stored inside the liver along with blood markers of sugar control, cholesterol, and low-grade body-wide inflammation.

    Testing daily peanut intake in a crossover trial

    The study was prospectively registered on ClinicalTrials.gov and carried out at Maastricht University between February 2023 and July 2024, with the supporting data included in the published paper and further details available from the corresponding author on request. Prior power calculations showed that at least 27 participants were needed to detect a 7.5 percent change in brain blood flow, a sample size the team’s earlier trials indicated was also sufficient to detect effects on regional brain insulin responsiveness.

    The researchers enrolled 36 community-dwelling adults aged 60 to 75 with a body mass index (BMI) between 20 and 35, all of whom were right-handed, non-smokers, and free of diabetes, cardiovascular disease, and peanut allergies. Five enrollees withdrew early, including one woman who stopped due to digestive discomfort after eating peanuts and four participants assigned to begin with the control period who left due to scheduling conflicts, personal reasons, or not following the study protocol, leaving 31 participants (16 men and 15 women, average age 67) who completed the entire trial.

    In this single-blind, randomized crossover trial, each volunteer served as their own control by completing two 16-week periods in random order, separated by an eight-week break to let any dietary effects wear off. During the peanut phase, participants ate 60 grams per day, roughly two servings, of unsalted, skin-roasted runner-type peanuts, providing 340 calories and 29.5 grams of mostly unsaturated fat, with the antioxidant- and fiber-rich skins left intact and eaten whole without heating or crushing.

    During the control phase, participants abstained from peanuts, and throughout both phases they avoided other nuts and seeds while all scientists analyzing the scans and bloodwork remained blinded to group assignment. Among those who completed the trial, returned packets and daily food diaries indicated a median compliance rate of 100 percent.

    At the end of each 16-week period, participants arrived after a 12-hour overnight fast, 24 hours without alcohol, and 48 hours without vigorous exercise, traveling to the clinic by car or public transit to avoid physical exertion before testing. To measure brain insulin responsiveness, the researchers used a noninvasive brain scan called pseudo-continuous arterial spin labeling magnetic resonance imaging (MRI). This technique magnetically tags water molecules in arterial blood in the neck to track blood flow through brain tissue without radiation or contrast dyes.

    Participants underwent brain scans before and 30 minutes after receiving four puffs of insulin nasal spray, totaling 160 international units, which delivers the hormone rapidly to the brain along nasal pathways without triggering dangerous drops in systemic blood sugar. The researchers then compared voxel-by-voxel changes in brain blood flow before and after the spray across the entire brain, excluding the cerebellum, applying family-wise error correction for multiple comparisons while statistically accounting for trial period and sex.

    During the same week-16 imaging visit, abdominal MRI scans quantified the percentage of fat stored inside liver tissue for 30 participants, as one scan lacked sufficient image quality. Fasting blood samples were also drawn at the start, midpoint (week 8), and end (week 16) of each phase to measure blood glucose, insulin, calculated peripheral insulin resistance, cholesterol fractions, triglycerides, and high-sensitivity C-reactive protein, an indicator of low-grade systemic inflammation. Because these blood biomarkers were treated as exploratory outcomes, the statistical models adjusted for baseline levels, sex, and trial period without applying corrections for multiple comparisons.

    Changes in memory-related brain regions

    Adding the daily packets of peanuts increased participants’ average daily calorie intake by about 0.9 megajoules (roughly 215 calories) and shifted their diets toward more unsaturated fat and fiber alongside less carbohydrate, saturated fat, and dietary cholesterol. Even with those extra calories, changes in waist circumference and body fat percentage were not statistically significant across the trial.

    When the researchers examined large brain divisions as a whole, including total gray matter, cortical tissue, subcortical tissue, and global brain blood flow (which averaged roughly 40 to 44 milliliters per 100 grams of tissue per minute), differences in how blood flow reacted to the insulin spray were not statistically significant between the two phases.

    However, whole-brain cluster analysis pinpointed one localized region of 552 cubic millimeters in the right hemisphere where blood flow dropped more strongly after intranasal insulin following the peanut phase than following the control phase, with an average difference of 5.4 milliliters per 100 grams of tissue per minute. Brain-atlas probabilities placed this cluster mainly across structures tied to memory processing: the lingual gyrus (20 percent), the hippocampus (14 percent), and the neighboring parahippocampal gyrus (11 percent), with slight overlap in the thalamus and posterior cingulate gyrus.

    “Peanut consumption beneficially affected insulin responsiveness in a brain region involved in memory,” Joris said. “This provides an additional potential mechanism through which peanut consumption may benefit cognitive performance.”

    At first glance, a drop in regional blood flow after an insulin spray might sound counterintuitive, since greater baseline blood flow is generally considered healthier for blood vessels. The authors explain that inside the hippocampus, insulin normally boosts inhibitory chemical signals that quiet down nerve-cell firing, and because local blood supply is coupled to nerve activity, a stronger dip in blood flow after insulin administration may reflect more efficient neural regulation, matching a pattern seen in a 2021 neuroimaging study of young men with normal weight or overweight.

    Even so, when the researchers tested whether individual shifts in this regional insulin response tracked directly with the verbal recognition memory gains seen in the trial, the correlation was not statistically significant. Unlike the primary group comparison, the trial was not statistically powered to detect person-to-person correlations, and the authors note that biological variability or a non-linear relationship between insulin signaling and memory could mask a direct link.

    Liver fat, blood markers, and proposed nutrients

    These brain imaging results align with a 2024 crossover trial of older adults with overweight or obesity conducted by four of the same authors and published in the American Journal of Clinical Nutrition, which found that eating 60 grams of mixed tree nuts daily for 16 weeks altered insulin responsiveness in occipital and frontal brain clusters, including the lingual gyrus, without changing body weight or peripheral insulin sensitivity.

    Unlike that mixed-nut study, which reduced liver fat by 15 percent, the peanut intervention left liver fat virtually unchanged at 5.3 percent versus 5.0 percent after the control phase, a difference that was not statistically significant. The authors suggest that mixed tree nuts may be more effective at curbing liver fat because they supplied roughly twice as much polyunsaturated linoleic acid (10 grams per day) as peanuts (5.6 grams per day), which contain mostly monounsaturated fats.

    Across the exploratory blood panels, differences between the peanut and control phases were not statistically significant for fasting glucose, fasting insulin, peripheral insulin resistance, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, or C-reactive protein. Blood triglycerides dipped modestly halfway through the peanut period at week 8, averaging 0.20 millimoles per liter lower than during the control period, before returning to baseline levels by week 16. Together, those results indicate that daily peanut intake altered regional brain responses to insulin without shifting standard metabolic risk markers in the bloodstream.

    Although the trial was not designed to isolate individual chemical compounds, the authors propose several nutrients in skin-roasted peanuts that might contribute to the brain response. Peanuts are rich in plant protein and carry high levels of L-arginine, an amino acid the body converts into nitric oxide, a molecule that helps blood vessels relax and supports communication between memory cells in the hippocampus. Leaving the peanut skins intact also supplied dietary fiber and polyphenol antioxidants alongside unsaturated fats, vitamin E, and magnesium, which the researchers suggest could act together to influence insulin signaling in the brain.

    Study caveats and questions for future research

    As with all research, there are some caveats to consider, starting with the fact that the study was funded by a grant from The Peanut Institute Foundation, although the organization had no role in designing the trial, collecting or analyzing the data, writing the paper, or deciding to publish, and the authors reported no conflicts of interest. Because participants ate recognizable whole peanuts without a calorie- and nutrient-matched control snack lacking peanut-specific compounds, they knew which phase they were in, and part of the observed brain effect could stem from eating fewer carbohydrates and saturated fats rather than from peanuts alone.

    In addition, blood-flow changes measured after a nasal insulin spray offer only an indirect window into nerve-cell signaling, and scientists are still working out how insulin-driven blood-flow shifts vary in direction across different brain structures. The study design also could not measure how much this regional insulin response contributed to improved memory relative to broader improvements in blood vessel health.

    “It is important to note that these findings come from a mechanistic study in healthy older adults, with a dietary intervention lasting 16 weeks,” Joris noted. “Larger and longer studies are needed to confirm whether these effects are maintained with habitual intake over time and whether similar benefits occur in other target populations, including people with cognitive impairment. Future studies should also examine different peanut preparations.”

    Because volunteers in the Maastricht trial ate whole, uncrushed, unsalted peanuts with their skins intact, testing other common options such as peanut butter, roasted skinless peanuts, or salted varieties will be necessary to see whether processing or added sodium changes the results. Future experiments analyzing isolated nutrients will also be needed to pinpoint which specific bioactive ingredients in peanuts influence insulin action in the aging brain.

    The study, “Daily consumption of unsalted, skin-roasted peanuts beneficially affects regional brain insulin responsiveness in older adults: Results of a longer-term randomized controlled trial,” was authored by Lucia Kerkhof, Ronald P. Mensink, Jogchum Plat, Kevin M.R. Nijssen, and Peter J. Joris.

    URL: psypost.org/daily-peanut-consu

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Peanuts #BrainHealth #HealthyAging #Memory #Nutrition #InsulinResistance #CognitiveHealth #HealthyEating #ClinicalResearch #Wellness

  2. Five surprising ways to boost your iron – that have nothing to do with meat

    In a study that measured iron absorption from fortified foods, researchers found that iron absorption from infant cereals…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Nutrition #Article #future #Health #health-tag/food-tag/nutrition-tag/science-tag/features #Story
    newsbeep.com/us/922275/

  3. New healthy takeaway ‘No Nonsense’ to be launched

    Coco Ross runs a meal prep business called RTR Nutrition and recently decided to branch-out by opening an…
    #NewsBeep #News #Nutrition #Health #UK #UnitedKingdom
    newsbeep.com/uk/839107/

  4. Libby Birch’s day on a plate: What an AFLW star and physiotherapist eats to fuel her training

    November 19, 2026 — 5:00am Save You have reached your maximum number of saved items. Remove items from your saved list to add more. No gift articles left You’ve used all of your gift articles. 3 more will become availab…
    #dining #cooking #diet #food #Nutrition #nutrition
    diningandcooking.com/2896994/l

  5. Libby Birch’s day on a plate: What an AFLW star and physiotherapist eats to fuel her training

    November 19, 2026 — 5:00am Save You have reached your maximum number of saved items. Remove items from…
    #NewsBeep #News #Nutrition #AU #Australia #Health
    newsbeep.com/au/969478/

  6. From microbiome to mind and mood: Celebrating ingredient innovation at the 2027 NutraIngredients Europe Awards

    Entries are now open for the 2027 NutraIngredients Europe Awards, with 19 categories available to enter, including seven…
    #NewsBeep #News #Nutrition #CA #Canada #Health #up
    newsbeep.com/ca/975795/

  7. From microbiome to mind and mood: Celebrating ingredient innovation at the 2027 NutraIngredients Europe Awards

    Entries are now open for the 2027 NutraIngredients Europe Awards, with 19 categories available to enter, including seven…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Nutrition #Health #up
    newsbeep.com/us/922067/

  8. DATE: November 18, 2026 at 08:00PM
    SOURCE: PSYPOST.ORG

    ** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
    -------------------------------------------------

    TITLE: GLP-1 drugs linked to reduced alcohol use and healthier eating in real-world study

    URL: psypost.org/glp-1-drugs-linked

    Adults taking popular diabetes and weight-loss medications tended to cut back on alcohol and stick more closely to healthy diets over nearly a year of routine medical care, according to a new study published in Addictive Behaviors. Patients also reported feeling calm and peaceful more often, although broad measures of overall mental health and long-term physical activity did not show meaningful changes. The findings add real-world clinical evidence to growing scientific interest in how metabolic drugs might relate to everyday habits beyond blood sugar and weight control.

    Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications that includes drugs such as semaglutide and dulaglutide, mimic a natural hormone released in the gut after eating. By binding to specialized proteins called receptors on cells in the pancreas, stomach, and brain, these drugs stimulate insulin release, slow digestion, and promote feelings of fullness. Doctors prescribe them widely to lower blood sugar in people with type 2 diabetes and to support weight loss in people with obesity.

    Receptors for this hormone are not limited to regions that manage hunger and digestion. They also appear in the mesolimbic system, a network of deep brain structures that processes pleasure, motivation, and reward by releasing the chemical messenger dopamine. Animal experiments indicate that activating these receptors dampens dopamine surges triggered by addictive substances and reduces alcohol-seeking behavior.

    Human studies have begun testing whether similar patterns emerge in medical patients. In people diagnosed with alcohol use disorder, a 2025 randomized clinical trial found that nine weeks of low-dose semaglutide lowered weekly alcohol cravings and reduced the amount of alcohol participants drank in a laboratory test compared with a placebo. Outside of controlled trials, a 2026 survey of a nationally representative U.S. sample indicated that roughly 44 percent of drinkers who started a GLP-1 medication recalled cutting back on alcohol during their first three months of treatment.

    Whereas controlled clinical trials have focused largely on people seeking treatment for alcohol use disorder, most observational studies of everyday diabetes and obesity patients have relied on backward-looking medical record reviews or one-time surveys asking people to recall past habits. Less is known about how drinking, diet, exercise, and mood evolve together when tracked forward in time during routine metabolic care. Earlier work on the same patient dataset, reported in a 2026 study by several of the same authors, showed that 44 weeks of GLP-1 therapy improved body weight, blood sugar, physical functioning, and overall quality of life, while an overall mental health summary score did not show a statistically significant change.

    To examine day-to-day habits and specific emotional states in closer detail, study lead author José Seijas-Amigo and his colleagues reanalyzed data from that Spanish clinical cohort, known as the SEVERAL study. Seijas-Amigo is head of the Clinical Trials Unit for Cardiology and Intensive Cardiac Care in the Department of Cardiology at the University Clinical Hospital of Santiago de Compostela, and is affiliated with the Foundation Health Research Institute of Santiago de Compostela and the University of Santiago de Compostela in Spain. Because the original project was designed primarily to evaluate metabolic health and drug safety rather than drinking or behavioral changes, the researchers framed this follow-up investigation as an exploratory, hypothesis-generating analysis.

    “Addiction remains a major public health challenge, and pharmacological treatment options are still limited for many substance use disorders,” Seijas-Amigo told PsyPost. “This creates an important need to explore new therapeutic approaches, particularly medications that are already widely used for other conditions.”

    “Growing evidence suggests that GLP-1 receptor agonists may influence not only metabolic regulation but also biological pathways involved in reward and addictive behaviors,” he added. “Although this was a post hoc observational analysis, we wanted to contribute real-world evidence to help determine whether these early signals deserve further investigation in dedicated clinical trials.”

    The study followed 135 adults with both obesity and type 2 diabetes across multiple healthcare centers in Spain as they started or stepped up treatment with a GLP-1 medication as part of routine care. Participants had an average age of about 62 years, slightly more than half were men, and their average body mass index was 36.2, well above the threshold of 30 used to define obesity. Most patients had additional cardiovascular risk factors such as high blood pressure or abnormal cholesterol levels.

    “I would like to highlight the collaborative work behind the SEVERAL project, particularly the contribution of primary care pharmacists, and the importance of multidisciplinary research connecting cardiology, metabolic medicine, and addiction specialists,” Seijas-Amigo noted. “This is also an approach we aim to promote through the Cardiology Clinical Trials Unit in Santiago de Compostela, which I lead.”

    Doctors prescribed medications according to standard clinical judgment rather than random assignment. Roughly 35 percent of patients received dulaglutide, 31 percent took oral semaglutide, 30 percent used injectable semaglutide, and about 4 percent took liraglutide or exenatide. Over the 44-week study period, 43 percent of participants experienced an adverse drug reaction, with digestive issues such as nausea accounting for more than four-fifths of those cases. Among the 58 patients who experienced an adverse reaction, four stopped treatment permanently.

    Clinicians assessed lifestyle habits at the start of the study and again at weeks 4, 12, and 44. Participants reported their typical daily alcohol intake in standard drink units, with one unit defined in Spain as 10 grams of pure alcohol, or roughly one small glass of wine or beer. Responses were grouped into three categories: zero to one drink per day, two drinks per day, or more than two drinks per day.

    At those same visits, patients answered yes-or-no questions about whether they were following dietary recommendations and whether they were engaging in regular physical activity. At the beginning of treatment and at week 44, participants also completed two standardized health questionnaires that measure overall mental well-being, anxiety and depression, and specific emotional experiences over recent weeks, such as feeling calm and peaceful, feeling downhearted, or accomplishing less in daily tasks because of emotional difficulties.

    Even before starting treatment, drinking levels in this group were generally low. Among the 130 patients with complete alcohol records, 87.7 percent already fell into the lowest category of zero to one standard drink per day, while 6.9 percent reported two drinks per day and 5.4 percent reported more than two.

    Over 44 weeks of therapy, self-reported drinking shifted downward across those categories. By the final visit, 96.2 percent of participants were in the zero-to-one drink group, 3.8 percent reported two drinks per day, and none reported drinking more than two units daily.

    Adherence to dietary advice also rose over the course of treatment. At the initial visit, 47.7 percent of participants reported following their recommended diet, a share that climbed to 66.7 percent at week 4 and settled at 63.2 percent at week 44. That improvement held steady when the researchers used statistical techniques to account for missing follow-up answers.

    Physical activity followed a different trajectory. The proportion of patients reporting regular exercise climbed from 43.9 percent at the start to 56.1 percent at week 12, before slipping back to 50.4 percent by week 44. Comparing the start of the study with week 44, that long-term difference in physical activity was not statistically significant, a finding that remained unchanged after accounting for missing follow-up data.

    “What I found particularly interesting was that not all lifestyle behaviors changed in the same way,” Seijas-Amigo observed. “We observed a shift toward lower categories of alcohol consumption and improved dietary adherence, but these changes were not accompanied by sustained improvements in physical activity.”

    “This suggests that changes in health-related behaviors during GLP-1 receptor agonist therapy may be more complex than a general improvement in lifestyle,” he continued. “It raises interesting questions about whether different behavioral pathways are involved, although our study was not designed to investigate the underlying mechanisms.”

    Broad assessments of mental health showed little overall movement over the 44 weeks. Changes in the general mental health summary score, which averaged 50.3 at baseline and 52.2 at week 44, were not statistically significant, and a separate rating of anxiety and depression problems also did not reach statistical significance.

    When the researchers looked individually at specific mood questions in exploratory checks, one item stood out. The share of patients who reported feeling calm and peaceful all or most of the time rose from 51.9 percent at the beginning of treatment to 69.2 percent at week 44. Downward shifts in daily limitations from emotional problems were much more tentative: a drop in accomplishing less than desired sat right on the statistical borderline, and a reduction in working with less attention than usual fell slightly short and was not statistically significant.

    Reports of feeling downhearted and blue, meanwhile, barely budged over the 44 weeks and were nowhere near statistically significant. Because the team tested multiple emotional items without statistical adjustments for repeated testing, the authors note that the increase in calmness could reflect a chance finding and should be read cautiously.

    “I was also interested in the changes observed in certain aspects of emotional well-being, but these findings were exploratory and did not translate into statistically significant improvements in overall mental health measures,” Seijas-Amigo noted.

    The downward shift in drinking aligns with a randomized placebo-controlled trial of adults with alcohol use disorder and obesity, which found that weekly semaglutide reduced heavy drinking days. That trial evaluated addiction patients rather than routine drinking categories in people with type 2 diabetes, yet both studies point toward lower alcohol intake during treatment. A similar pattern emerged in a health-registry study of patients with alcohol use disorder, which linked semaglutide and liraglutide to fewer alcohol-related hospitalizations rather than tracking self-reported drinking in people with diabetes and obesity.

    In interpreting their results, the authors suggest several overlapping possibilities for why eating habits, drinking, and feelings of calmness shifted during therapy. Losing weight and gaining better control over blood sugar might boost how patients feel about their health and reinforce healthier routines. The researchers also propose that GLP-1 signaling in brain regions tied to appetite, stress, and reward could make rich foods and alcoholic beverages less enticing, though they caution that their study did not measure brain activity, cravings, or impulsivity directly.

    Even with growing interest in how metabolic therapies might relate to behavior, Seijas-Amigo emphasized that everyday habits remain foundational. “For the general public, the most important message is that maintaining a healthy diet and avoiding alcohol consumption remain essential strategies for improving long-term health,” he said. “From a health perspective, drinking less is generally better, and not drinking alcohol is the safest option. Medications may eventually provide additional benefits, but they should never be viewed as a substitute for healthy lifestyle choices.”

    There are a few things to keep in mind when interpreting these results. Because this was an observational study without an untreated comparison group, it cannot establish that the medications caused the behavioral changes. Regular checkups with healthcare providers, routine lifestyle advice, weight loss itself, or even digestive side effects like nausea could lead patients to eat differently and turn down alcoholic drinks.

    In addition, nearly nine out of ten participants already drank one standard unit or less per day before starting the medication, leaving only 16 patients in the higher drinking brackets. Grouping zero drinks and one daily drink into a single category meant the questionnaire could not detect whether light drinkers quit altogether or cut back slightly, and no clinical screening tools for problem drinking were used. The findings also come from older adults managing obesity and type 2 diabetes in Spain, meaning they may not apply to younger people or to individuals seeking treatment for alcohol addiction.

    Because of those baseline and measurement limits, Seijas-Amigo cautioned that “we cannot determine how much alcohol individuals actually reduced or whether these changes translated into meaningful long-term health benefits.”

    “The changes we observed were encouraging, but their practical significance should be interpreted carefully,” he added. “I would consider these findings an interesting clinical signal rather than evidence of a large therapeutic effect. Their main value is helping identify questions that should be tested in larger, controlled clinical trials.”

    “The most important misconception to avoid is that our study demonstrates that GLP-1 receptor agonists can treat alcohol addiction. It does not,” Seijas-Amigo stressed. “I believe these findings support further research, but they should not encourage people to use GLP-1 medications specifically to reduce alcohol consumption outside established medical indications. Promising biological hypotheses must ultimately be confirmed by well-designed randomized clinical trials.”

    Future studies built specifically to track alcohol use and mental health will be needed to test whether these everyday behavioral shifts hold up under stricter conditions. Controlled trials that use detailed drinking logs, validated craving scales, and biological markers of alcohol intake could help clarify whether GLP-1 therapies directly alter reward-driven habits or work mainly through broader improvements in physical health.

    “My main goal is to help move this field from promising observational findings to rigorous randomized clinical trials that can establish whether GLP-1-based therapies have a meaningful role in treating addictive disorders,” Seijas-Amigo explained. “I believe the priority now is to conduct well-designed clinical trials with clinically meaningful outcomes, such as sustained abstinence, relapse prevention, and long-term safety. These studies should be encouraged regardless of whether they are led by pharmaceutical companies, hospitals, or universities. Ultimately, what matters is generating robust, independent, and reproducible evidence that can determine whether these therapies offer real benefits to patients.”

    Researchers are also beginning to look at related drugs such as tirzepatide, a newer diabetes and weight-loss medication that targets both GLP-1 receptors and a second gut hormone receptor involved in metabolism and appetite. Preclinical work, including a laboratory study in rodents that examined controlled drinking and brain reward signaling rather than self-reported alcohol intake in adult clinical patients, similarly linked tirzepatide to lower alcohol consumption, and scientists are exploring whether such medications might affect other addictive behaviors like smoking.

    “In fact, I previously developed a research proposal to investigate tirzepatide as a potential aid for smoking cessation in patients with cardiovascular disease,” Seijas-Amigo added. “Although the project did not ultimately receive funding, it reflects my interest in exploring the intersection between cardiovascular health, addiction, and pharmacological innovation.”

    “Finally, addiction remains highly stigmatized, sometimes even within healthcare,” Seijas-Amigo said. “We need greater recognition of addiction specialists and multidisciplinary treatment teams, better access to evidence-based pharmacological and psychological therapies, and more clinical research. People with substance use disorders deserve the same scientific attention and quality of care as patients with any other medical condition.”

    The study, “Alcohol consumption, lifestyle behaviors, and emotional well-being during GLP-1 receptor agonist therapy: a post hoc analysis of the several study,” was authored by José Seijas-Amigo, Ángel Salgado-Barreira, Rosana Castelo-Dominguez, María Teresa Pérez-Álvarez, Belén Ponce-Piñón, Marlén Fernández-Silva, Marta Rodríguez-Barreiro, Mercedes Pereira-Pía, Jose Manuel Iglesias-Moreno, Mar Gago-García, Raquel Montáns-García, Agustina Fernandez-Perez, Dolores Fraga-Gayoso, Montse Fernandez-Montenegro, Beatriz Riveiro-Barciela, Natalia Rilla-Villar, Begoña Cardeso-Paredes, Marta Ribeiro-Ferreiro, Diego Rodriguez-Penas, Alberto Cordero, Moisés Rodríguez-Mañero, José R. González-Juanatey, and Several Investigators.

    URL: psypost.org/glp-1-drugs-linked

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #GLP1 #Semaglutide #WeightLoss #Diabetes #AlcoholResearch #HealthyEating #Nutrition #HealthResearch #AddictionResearch #ClinicalStudy

  9. From microbiome to mind and mood: Celebrating ingredient innovation at the 2027 NutraIngredients Europe Awards

    Entries are now open for the 2027 NutraIngredients Europe Awards, with 19 categories available to enter, including seven…
    #NewsBeep #News #Nutrition #Health #UK #UnitedKingdom #up
    newsbeep.com/uk/838639/

  10. Your hair-growth supplements could be messing with your bloodwork

    Your quest for luscious locks could be putting more than your hairline at risk. More than 80 million Americans are affected by hair loss, and many turn to supplement…
    #dining #cooking #diet #food #Nutrition #bloodtests #cancer #exclusive #hairloss #health #heartattacks #Hormones #nutrition #screenings #supplements #wellness
    diningandcooking.com/2896427/y

  11. Your hair-growth supplements could be messing with your bloodwork

    Your quest for luscious locks could be putting more than your hairline at risk. More than 80 million…
    #NewsBeep #News #Nutrition #bloodtests #CA #Canada #cancer #Exclusive #hairloss #Health #heartattacks #hormones #screenings #supplements #wellness
    newsbeep.com/ca/975377/

  12. Your hair-growth supplements could be messing with your bloodwork

    Your quest for luscious locks could be putting more than your hairline at risk. More than 80 million…
    #NewsBeep #News #Nutrition #bloodtests #cancer #Exclusive #HairLoss #Health #heartattacks #hormones #screenings #Supplements #UK #UnitedKingdom #wellness
    newsbeep.com/uk/838569/

  13. Diet-microbiome interaction shapes stress susceptibility via a gut-brain neurometabolic circuit.

    Microbial L-pipecolic acid links diet to brain circuits that promote #stress resilience.

    #microbiology #nutrition #microbiota #metabolism #brain

    davidojcius.blogspot.com/2026/

  14. Your hair-growth supplements could be messing with your bloodwork

    Your quest for luscious locks could be putting more than your hairline at risk. More than 80 million…
    #NewsBeep #News #Nutrition #AU #Australia #bloodtests #Cancer #Exclusive #HairLoss #Health #heartattacks #hormones #screenings #supplements #wellness
    newsbeep.com/au/968946/

  15. The healthiest fruit and veg to eat this autumn, according to dietitians

    Looking to give your diet a seasonal refresh? Autumn is packe…
    #dining #cooking #diet #food #Nutrition #content-type:Feature #contentId:d40d5e92-e535-462e-83bb-c207c81ef809 #displayType:standardarticle #isSyndicated:false #locale:GB #nutrition #shortTitle:Thehealthiestfruitandvegtoeatthisautumn #sponsored:false
    diningandcooking.com/2895968/t

  16. The healthiest fruit and veg to eat this autumn, according to dietitians diningandcooking.com/2895968/t #ContentType:Feature #ContentId:D40d5e92E535462e83bbC207c81ef809 #DisplayType:StandardArticle #IsSyndicated:False #Locale:GB #nutrition #ShortTitle:TheHealthiestFruitAndVegToEatThisAutumn #Sponsored:False

  17. Get vaccinated, don’t vape – and moisturise liberally! 10 doctors on how to avoid and treat winter ailments
    By Sarah Phillips

    The nights are drawing in, the temperature is dropping, festive overindulgence is on the horizon and it’s easy to get run down. Here’s some expert advice to help you safely through the season

    theguardian.com/lifeandstyle/2

    #Lifeandstyle #Health #Society #Christmas #Fitness #Healthwellbeing #Nutrition #Sleep #Flu #TheGuardian #SarahPhillips

  18. Appetite suppression causes unrecognized severe calorie drops without dietary guidance

    Drugs taken to suppress appetite, such as Wegovy and Mounjaro, are associated with inadequate intakes of key nutrients…
    #NewsBeep #News #Health #appetite #AU #Australia #diabetes #Diary #Drugs #food #Nutrients #Nutrition #Obesity #protein #research #type2diabetes #vitamind
    newsbeep.com/au/968378/

  19. In honor of the olive harvest season: Everything you need to know about olives

    A tarpaulin spread out beneath a tree, children shaking branches, someone using a stone to crack each olive and transfer it into a container with water and …
    #dining #cooking #diet #food #MediterraneanOliveOil #OliveOil #health #healthyeating #Mediterranean #nutrition #Olive #oliveharvest #olivetree
    diningandcooking.com/2895677/i

  20. How to Eat Your Favorite Holiday Foods and Meet Your Nutrition Goals

    Key Takeaways Balance holiday favorites with the plate method: half vegetables, one-quarter protein, and one-quarter starches like stuffing or mashed potatoes. Eating balanced meals throughout the day can help you avoid extreme hunger and make m…
    #dining #cooking #diet #food #Nutrition #healthyholidayeating #nutrition
    diningandcooking.com/2895562/h

  21. Newer generations show better memory and slower cognitive decline

    “For the first time, we can show that newer generations not only enter old age with better memory,…
    #NewsBeep #News #Health #Brain #CA #Canada #Dementia #education #Genetic #medicine #Nutrition #psychology #research
    newsbeep.com/ca/974583/

  22. FitLife Brands Announces Third Quarter 2026 Results

    OMAHA, NE, Nov. 16, 2026 (GLOBE NEWSWIRE) — FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Nutrition #FitLifeBrands #Health #Inc. #Nasdaq:FTLF
    newsbeep.com/us/920936/

  23. Kids’ diets linked to mental health and learning

    An after-school snack or dinner at Nan and Pop’s can be a chance to help grandchildren build healthy…
    #NewsBeep #News #Health #AU #Australia #Children'smentalhealth #Children'sHealth #FlindersUniversity #grandparenting #HealthyEating #Nutrition #RaineStudy #WesternAustralia
    newsbeep.com/au/968210/

  24. Five foods that hit the protein-fibre sweet spot

    Once the preserve of weightlifters and athletes, high-protein diets have gone mainstream in recent years. Increasingly, we’re piling…
    #NewsBeep #News #Nutrition #bloodpressure #diabetes #Diet #Health #Healthandfitness #Nutritionanddieting #Spine #standard #UK #UnitedKingdom #UScontent
    newsbeep.com/uk/837821/

  25. Forty percent protein by dry weight. That's among the highest of any plant food there is, and it costs less than a cup of coffee.

    Lupini fed Mediterranean and Andean households for thousands of years before an American grocery store decided they were a novelty in a jar by the olives.
    #FoodAsMedicine #Lupini #Legumes #PlantProtein #Cooking #Foodstodon #Nutrition #FoodSovereignty #Frugal #MutualAid #Mediterranean
    1/3

  26. 16 Gluten-Free BBQ Potato Chips, Ranked










    Amy Bell/Tasting Table We may receive a commission on purchases made from links. When I recently had to switch back to a gluten-free diet, the most surprising food I saw people talking about in regards to gluten-free options was BBQ potato chips. Since BBQ is [...]
    #dining #cooking #diet #food #Nutrition #nutrition
    diningandcooking.com/2895264/1

  27. Why are so many young women getting obsessed with creatine?

    Campbell Gulbrandsen, a fashion assistant living in New York City, says she was on the creatine wave “before…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Nutrition #art #dazed #dazed&confused #dazed&confusedmagazine #dazedandconfused #dazedandconfusedmagazine #dazed+confused #dazeddigital #fashion #Film #Health #ideas #ideassharingnetwork #Music
    newsbeep.com/us/920636/

  28. Creatine & Cognition: The Next Frontier

    Creatine is entering a new era. Long established as one of the most recognized ingredients in sports nutrition,…
    #NewsBeep #News #Nutrition #AU #Australia #Health
    newsbeep.com/au/967912/

  29. Enjoy Thanksgiving Without Overlooking Your Health: A TCM Perspective on Digestion and Balance…..and People….

    Thanksgiving is a time for family, friends, gratitude, and, of course, food. From roasted turkey and stuffing to mashed potatoes, maybe some hot pot, throw in some tacos, even fish out the sushi. The holiday table often brings together some of our favorite meals of the year. But after a large holiday dinner, it is not unusual to experience bloating, fullness, sluggishness, or general digestive discomfort. The good news? Enjoying Thanksgiving and taking care of your health do not have to be […]

    theakupunctureclinic.wordpress

Share on Mastodon

Enter the server where you have an account.